Search

GlaxoSmithKline PLC

Отворен

СекторЗдравеопазване

1,888.5 -0.18

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1848.5

Максимум

1911.5

Ключови измерители

By Trading Economics

Приходи

1.1B

1.5B

Продажби

478M

8.9B

P/E

Средно за сектора

17.051

51.78

EPS

0.546

Дивидентна доходност

4.26

Марж на печалбата

17.362

Служители

66,841

EBITDA

689M

3.3B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+10.44% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

4.26%

1.96%

Следващи печалби

3.02.2027 г.

Следваща дата на дивидент

7.01.2027 г.

Следваща дата на екс-дивидент

12.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-3.6B

73B

Предишно отваряне

1888.68

Предишно затваряне

1888.5

GlaxoSmithKline PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.11.2026 г., 23:56 ч. UTC

News
Social Media

Trimble Inc appoints Matthew C. Brown, former CFO of Tenable Holdings, to its Board of Directors in after-market trading.

4.11.2026 г., 23:52 ч. UTC

News

Uranium Energy Corp. is trading modestly higher in after-market hours following fluctuations since Wednesday's close.

4.11.2026 г., 23:51 ч. UTC

News

Watts Water Technologies reports Q3 net sales of $728 million, exceeding estimates, with diluted EPS of $4.34 and raises full-year sales growth outlook to 17%-18%.

4.11.2026 г., 23:46 ч. UTC

News
Correlated Moves

Chord Energy reports Q3 adjusted EPS of $6.08, exceeding estimates, while revenues of $1.71B missed expectations; raises 2026 adjusted EBITDA guidance to $3.4B.

4.11.2026 г., 23:46 ч. UTC

News

UBS maintains Neutral rating on Coca-Cola Europacific Partners PLC and raises price target to $115 in a report published after the market closed.

4.11.2026 г., 23:41 ч. UTC

News
Correlated Moves

Nasdaq Inc reported a decline in October trading volume to 4.4 billion shares, down from 5.2 billion in September, contributing to its negative performance.

4.11.2026 г., 23:41 ч. UTC

News

Evolus Inc reports Q3 results with EPS of -$0.19, missing estimates, while revenue of $78 million exceeds expectations and marks a 13% year-over-year increase.

4.11.2026 г., 23:41 ч. UTC

News

UBS reaffirms Buy rating on Expeditors International and raises price target to $245, citing strong operational performance in the logistics sector.

4.11.2026 г., 23:41 ч. UTC

Social Media
News

Ellington Financial reported Q3 adjusted EPS of $0.45, meeting consensus but missing the analyst estimate of $0.47, contributing to a decline in after-market hours.

4.11.2026 г., 23:41 ч. UTC

News

Coca-Cola Co shares rose in after-market trading, reaching their highest point of the day with 41k options contracts exchanged and calls outpacing puts.

4.11.2026 г., 23:36 ч. UTC

Social Media
News

Cytokinetics reports Q3 net loss of $190.1 million, or $1.37 per share, better than expected; revenue reaches $47.6 million, exceeding estimates.

4.11.2026 г., 23:31 ч. UTC

News

Brown & Brown Inc's shares advanced modestly in after-market hours, settling near a cumulative return of 0.79% above the previous close.

4.11.2026 г., 23:31 ч. UTC

News

Citigroup maintains Buy rating on Gaming and Leisure Properties, Inc. but lowers price target to $49, citing recent market conditions affecting the sector.

4.11.2026 г., 23:31 ч. UTC

News

UBS maintains a Buy rating on Amgen and raises its price target to $530, with Scotiabank also upholding its Sector Outperform rating at the same level.

4.11.2026 г., 23:31 ч. UTC

News

Pacific Biosciences reports Q3 revenue of $40.6 million, exceeding expectations, and narrows 2026 revenue guidance to $155 million to $160 million.

4.11.2026 г., 23:26 ч. UTC

News

Goldman Sachs and Apollo are reportedly marketing a $40 billion AI chip financing deal for SpaceX, seeking buyers for portions up to $500 million.

4.11.2026 г., 23:21 ч. UTC

News

STAAR Surgical Company announces a $50 million share repurchase program and reports third-quarter net sales of $83.4 million, exceeding expectations.

4.11.2026 г., 23:21 ч. UTC

News

Citi analyst Ariel Rosa raised ArcBest Corporation's price target to $175.00 from $170.00 while maintaining a Buy rating.

4.11.2026 г., 23:21 ч. UTC

News

Mativ Holdings reports Q3 results with adjusted EPS of $0.31 and revenue of $499.5 million, missing estimates, and records a GAAP loss of $1.2 million.

4.11.2026 г., 23:21 ч. UTC

News

UBS maintains Neutral rating on Henry Schein, Inc. and raises price target to $95, with shares advancing significantly in after-market trading.

4.11.2026 г., 23:21 ч. UTC

Correlated Moves
News

UBS maintains a Neutral rating on Gartner, Inc. while raising its price target to $220, as shares decline in after-market trading.

4.11.2026 г., 23:16 ч. UTC

News
Correlated Moves

Franklin Templeton reported preliminary assets under management of $1.81 trillion as of October 31, 2026, following $3 billion in long-term net inflows.

4.11.2026 г., 23:16 ч. UTC

News
Correlated Moves

Huntington Ingalls Industries shares are modestly lower in after-market trading, while General Dynamics also sees slight declines amid recent volatility.

4.11.2026 г., 23:11 ч. UTC

News

Scotiabank maintains Sector Perform rating on Block, Inc. and raises price target to $89, as shares decline in after-market trading.

4.11.2026 г., 23:11 ч. UTC

News

Qualcomm's CEO confirmed the Dragonfly c1000 CPU is on track to ship to Meta Platforms, potentially enhancing Meta's product capabilities.

4.11.2026 г., 23:11 ч. UTC

Social Media
Correlated Moves
News

Booking Holdings Inc. declines in after-market trading as Citigroup lowers its price target to $220, while UBS raises its target to $267, maintaining a Buy rating.

4.11.2026 г., 23:06 ч. UTC

Social Media
News

Amplitude, Inc. reported third-quarter 2026 revenue of $110.6 million, exceeding estimates, and raised its full-year revenue guidance to between $415.8 million and $418.2 million.

4.11.2026 г., 23:06 ч. UTC

News

Compass Inc. faces a class action lawsuit in New York over alleged misleading statements regarding its merger with Anywhere, impacting investor sentiment.

4.11.2026 г., 23:06 ч. UTC

News

3D Systems reports Q3 net loss of $33.5 million and adjusted EPS of ($0.06), while revenue of $99.3 million exceeds estimates but Q4 outlook falls short.

4.11.2026 г., 23:06 ч. UTC

Correlated Moves
News

Allstate Corp reported a significant decline in third-quarter net income to $2.05 billion, driven by higher expenses and increased catastrophe losses.

GlaxoSmithKline PLC Прогноза

Ценова цел

By TipRanks

10.44% нагоре

12-месечна прогноза

Среден 2,087.286 GBX  10.44%

Висок 3,004 GBX

Нисък 1,700 GBX

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за GlaxoSmithKline PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

15 ratings

3

Купи

9

Задържане

3

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
help-icon Live chat